| Richard T. Clark
|
| Chairman of the Board, President, Chief Executive Officer
|
|
|
Age: 62
Bio & Compensation - Reuters
|
| Peter N. Kellogg
|
| Chief Financial Officer, Executive Vice President
|
|
|
Age: 53
Bio & Compensation - Reuters
|
| Adam H. Schechter
|
| President - Global Pharmaceuticals
|
|
|
Age: 44
Bio & Compensation - Reuters
|
| Stefan Oschmann
|
| President, Europe, Middle East, Africa & Canada
|
|
|
Age: 51
Bio & Compensation - Reuters
|
| J. Chris Scalet
|
| Executive Vice President - Global Services, Chief Information Officer
|
|
|
Age: 50
Bio & Compensation - Reuters
|
| Bruce N. Kuhlik
|
| Executive Vice President, General Counsel
|
|
|
Age: 52
Bio & Compensation - Reuters
|
| Mirian M. Graddick-Weir
|
| Executive Vice President - Human Resources
|
|
|
Age: 54
Bio & Compensation - Reuters
|
| Kenneth C. Frazier
|
| Executive Vice President and President - Global Human Health
|
|
|
Age: 54
Bio & Compensation - Reuters
|
| Peter S. Kim Ph.D.
|
| Executive Vice President and President - Merck Research Laboratories
|
|
|
Age: 50
Bio & Compensation - Reuters
|
| Willie A. Deese
|
| Executive Vice President and President - Merck Manufacturing Division
|
|
|
Age: 53
Bio & Compensation - Reuters
|